About
This app provides comprehensive drug and therapeutic information for Nigeria, including essential medicines, treatment guidelines, and drug product details. It features an interaction checker, diagnosis and management of prevalent diseases, and a natural health products compendium. Designed for healthcare professionals, it offers enhanced search and detailed drug information.
What's New in EMDEX Reference
2.1.1
June 24, 2026
Payment process update.
Subscription plans
Querterly Plan
3 months subscription
User reviews
FAQ
What is EMDEX Reference?
EMDEX Reference is Nigeria’s trusted source for drug and therapeutic information, published since 1991. It is based on the WHO Model Formulary and Nigeria’s Essential Medicines Lists, detailing over 15,000 drug products approved for use in the country.
Who is EMDEX Reference for?
EMDEX Reference is exclusively for healthcare professionals. It serves as a reference aid and educational tool, not a substitute for professional judgment or medical advice.
What kind of drug information does EMDEX Reference provide?
It offers comprehensive drug product details, including adult and child dosages, renal dose adjustments, administration instructions, pharmacovigilance, advice to patients, nursing actions, drug use in pregnancy and lactation, and pack sizes.
Does EMDEX Reference have an interaction checker?
Yes, EMDEX Reference includes an interaction checker feature to help healthcare professionals identify potential drug interactions.
How often is EMDEX Reference updated?
The app's description states it has a regularly updated Drug Product Database. The last update was on 2026-04-30, indicating frequent updates.
Is EMDEX Reference available on all devices?
EMDEX Reference is available for iPhone, iPad, and iPod. It is designed for Apple devices.
Does EMDEX Reference contain advertisements?
Yes, EMDEX Reference contains advertisements. This is indicated by the 'hasAds' flag being true.
What is the rating of EMDEX Reference?
EMDEX Reference has a rating of 4.7 stars from 3 ratings, suggesting a generally positive user reception among its reviewers.





